Phuong Khanh Morrow

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Phuong Khanh Morrow

CRISPR Therapeutics AG reported in an 8-K filed December 19, 2023 that Phuong Khanh Morrow resigned as Chief Medical Officer, effective January 26, 2024.

“On December 14, 2023, Phuong Khanh Morrow, M.D., FACP resigned as Chief Medical Officer of CRISPR Therapeutics AG (the "Company") to be effective as of January 26, 2024.”

CRISPR Therapeutics AG Form 8-K, filed December 19, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Phuong Khanh Morrow's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

CRISPR Therapeutics AG (CRSP)
Proxy statement

Start not stated–2024-01-26

Company network

Recorded roles and call appearances connecting this person to public companies.

CRISPR Therapeutics AG

CRSP

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Chief Medical Officer CRISPR Therapeutics AG (CRSP)
2024-01-26